CAMP4 Therapeutics Corporation (CAMP) tiene un P/E histórico negativo de -3.0, lo que significa que la empresa actualmente no es rentable en base a los últimos doce meses (TTM). El rendimiento de ganancias histórico es -33.68%.
Criterios demostrados por esta página:
Puntuación General SharesGrow: 56/100 con 3/7 criterios aprobados.
| Year | P/E (TTM) | Ratio PEG | Ratio P/B | Ratio P/S | Rendimiento por Dividendo |
|---|---|---|---|---|---|
| 2017 | -53.8 | 0.38 | 2.35 | 1.10 | - |
| 2018 | 22.7 | -0.07 | 1.90 | 1.03 | - |
| 2019 | 20.2 | 1.58 | 1.80 | 1.02 | - |
| 2020 | -4.6 | 0.01 | 2.60 | 0.98 | - |
| 2021 | -17.3 | 0.23 | 3.68 | 1.19 | - |
| 2022 | -12.1 | -0.29 | 4.71 | 1.28 | - |
| 2023 | -8.8 | -3.85 | -4.99 | 0.00 | - |
| 2023 | -2.6 | -0.01 | -1.05 | 371.36 | - |
| 2024 | -2.0 | 0.06 | 1.61 | 156.16 | - |
| 2025 | -2.3 | 6.16 | 3.90 | 53.24 | - |
| Year | EPS (Diluido) | Ingresos | Ingreso Neto | Margen Neto |
|---|---|---|---|---|
| 2017 | $-0.20 | $351.1M | $-7.15M | -2% |
| 2018 | $0.46 | $365.91M | $16.62M | 4.5% |
| 2019 | $0.52 | $363.8M | $18.4M | 5.1% |
| 2020 | $-2.34 | $366.11M | $-78.77M | -21.5% |
| 2021 | $-0.62 | $308.59M | $-21.16M | -6.9% |
| 2022 | $-0.88 | $295.84M | $-31.15M | -10.5% |
| 2023 | $-0.90 | $294.95M | $-32.49M | -11% |
| 2024 | $-2.52 | $186.23M | $-93.26M | -50.1% |
| 2025 | $-2.66 | $652K | $-51.79M | -7943.4% |
| 2025 | $-2.65 | $3.5M | $-80.4M | -2298.5% |
| Year | EPS (Prom.) | Rango EPS | Ingresos (Prom.) | Rango de Ingresos | Analistas |
|---|---|---|---|---|---|
| 2026 | $-0.78 | $-0.93 – $-0.64 | $4.19M | $1.91M – $5.57M | 5 |
| 2027 | $-0.76 | $-0.92 – $-0.59 | $5.34M | $2.16M – $6.94M | 4 |
| 2028 | $-0.56 | $-0.74 – $-0.44 | $36.79M | $15.87M – $48.39M | 4 |
| 2029 | $-0.22 | $-0.31 – $-0.06 | $126.66M | $54.64M – $166.6M | 2 |
| 2030 | $-0.03 | $-0.04 – $-0.01 | $120.6M | $52.02M – $158.63M | 2 |
